/images/2023/09/14/woman_using_laptop.jpg)
/images/2019/12/06/smart_strategies_to_save_money_on_car_insurance.jpg)
:format(webp)/images/2026/07/22/what-trumps-new-generic-drug-tariffs-could-mean-for-the-medicines-mill_5KfB7eI.jpg)
/authors/chris-lewis-headshot.jpg)
/authors/andrea_basse_headshot.jpg)
Add Us On Google
Prescription drug costs have long been one of the biggest financial pressures facing retirees hoping to lower their financial stress in retirement. On July 1, 2026, Medicare began covering medications for weight management.
Specifically, Medicare began covering certain GLP-1 drugs, commonly used for diabetes and weight loss, with out-of-pocket costs dropping to around $50 per month for eligible retirees.
Now Available: The Definitive Guide to Retirement Income
Many successful investors eventually reach the same moment. The saving is done, the portfolio is built, and the question quietly changes from how much can I grow this to how much can I take out? Get that second question wrong and decades of good investing can come apart in a handful of years.
That is exactly what The Definitive Guide to Retirement Income helps answer.1 <p class="">Investing in securities involves a risk of loss. Past performance is never a guarantee of future returns. Investing in foreign stock markets involves additional risks, such as the risk of currency fluctuations. Guides are provided by Fisher Investments. The publisher may be compensated when readers request a guide.</p> It covers what your retirement could actually cost, which income sources are worth using, and the withdrawal math that decides whether the money lasts. It is free today from Fisher Investments. Read More Here ›
Coverage expansion for GLP-1 drugs
The policy targets a class of medications known as GLP-1 drugs, which include widely used treatments like Ozempic, Wegovy, and Zepbound. However, Ozempic is omitted from the list of eligible GLP-1 medications.
These drugs were originally developed to help manage blood sugar in people with Type 2 diabetes, but they have also gained widespread attention for their ability to support weight loss. Demand has surged in recent years, driven by both medical need and growing interest in their broader health benefits.
Eligible Medicare beneficiaries gain access to these medications at a significantly reduced price, potentially helping users who have struggled with affordability. KFF polling found that 56% of GLP-1 users said the drugs were difficult to afford, according to a November 2025 poll.
Significant price drop
The cost difference is what's drawing the most attention to the expanded coverage. Medicare enrollees who have Part D coverage and a BMI of 27 or higher plus a qualifying health condition are eligible for GLP-1 medications at $50/month.
For seniors currently paying out of pocket, that kind of reduction translates to thousands of dollars in annual savings. Even for those with partial coverage, lower negotiated pricing should ease monthly expenses and make long-term treatment more manageable.
Growing demand for GLP-1 medications
Interest in GLP-1 medications has exploded across the U.S. A 2025 survey found that roughly 1 in 8 American adults reported using a GLP-1 drug, with strong demand among older Americans.
Many Medicare beneficiaries manage chronic conditions like diabetes, while others are increasingly exploring these drugs for weight-related health concerns. The drugs have become a central part of treatment plans for millions of patients, even as their high price has limited access for others.
Released: The Definitive Guide to Retirement Income (Sponsor)
Most people spend their entire working lives focusing on one thing: growing a pile of money. Then they retire and discover the skill they actually need is close to the opposite. Turning that pile into steady income, year after year, through good markets and bad, without ever running out. It may be the least discussed and most consequential transition in personal finance, and plenty of otherwise careful investors walk into it with no real plan.
That is exactly what The Definitive Guide to Retirement Income helps answer.1 <p class="">Investing in securities involves a risk of loss. Past performance is never a guarantee of future returns. Investing in foreign stock markets involves additional risks, such as the risk of currency fluctuations. Guides are provided by Fisher Investments. The publisher may be compensated when readers request a guide.</p> It is a free guide from Fisher Investments covering what your retirement will really cost, where the cash flow should come from, and how much you can safely withdraw each year. Learn More Here ›
Medicare reach could be exponential
The scale of Medicare means any coverage change carries wide financial implications. More than 62 million Americans rely on Medicare for their health insurance, the majority of them age 65 and older. Expanding access to a high-cost category of drugs within that system shifts spending patterns both for individuals and the broader health care system.
Lower drug costs help seniors manage fixed incomes, especially as other expenses continue to rise.
Financial ripple effect
The potential savings go beyond just the monthly prescription cost, as lower out-of-pocket spending on medications frees up room in a retiree's budget for other essentials.
For example, if someone had previously paid hundreds of dollars per month, the shift to a $50 price point means they have thousands of dollars they can now put toward housing, food, or savings.
At the same time, broader access to these medications may reduce long-term health care costs if patients are better able to manage chronic conditions.
Policy context for GLP-1 drugs
With the Inflation Reduction Act of 2022, the Biden administration began negotiating lower prices for certain medications, targeting high-cost drugs used by Medicare beneficiaries. Expanding coverage for GLP-1 drugs fits into that larger strategy of making treatments more affordable for seniors.
Limits of coverage
Despite the headline savings, not every Medicare beneficiary may see the full benefit. Coverage depends on specific plan structures, including whether a drug is included on a plan's formulary and what conditions must be met for approval. Specifically, enrollees must have Part D and a BMI of 27 or higher, along with a qualifying medical condition.
The covered medications are also limited. The $50 copay applies to Wegovy (oral and injectable), the Zepbound KwikPen, and the Foundayo pill, but not Ozempic, a widely used GLP-1.
Temporary access
Eligible Medicare enrollees should note that reduced copay costs are temporary. The Medicare-GLP-1 Bridge, as it's known, is only available from July 1, 2026, through December 31, 2027.
Expanding coverage for expensive medications raises questions about long-term costs. While lower prices benefit individuals, the overall financial impact on Medicare depends on how widely the drugs are used and how pricing agreements are structured.
Increased utilization could drive higher total spending, even as per-patient costs decline. Balancing affordability with sustainability will likely remain part of the conversation.
Bottom line
Expanding Medicare coverage for GLP-1 drugs can save retirees hundreds of dollars for medications that previously cost far more.
Retirees reviewing money moves for senior benefits could see meaningful savings on a critical medication, making a difference in both their health and their financial fitness. The change improves access, eases financial strain, and supports better health outcomes.
More from FinanceBuzz:
- Retire like the rich: 14 ways you could build wealth in your 50s.
- Find out if you could pay less for car insurance in just a few clicks.
- Make these 7 savvy moves when you have $1,000 in the bank.
- 14 moves seniors could benefit from but often forget about.
/images/2021/04/21/adobestock_192812280_1200x628.jpg)
/images/2019/12/06/smart_strategies_to_save_money_on_car_insurance.jpg)
/images/2025/01/28/adobestock_628402894_1.jpeg)
/images/2024/09/04/adobestock_669069249_editorial_use_only_1.jpeg)
/images/2020/03/02/tattoo-woman-bar.jpeg)
/images/2020/12/21/smiling-couple-looking-at-laptop-screen.jpeg)
Intro Offer
UNLIMITED CASHBACK MATCH: Discover will automatically match all the cash back you’ve earned at the end of your first year! There’s no minimum spending or maximum rewards. You could turn $150 cash back into $300. Click Apply Now to view important rates and disclosures. Plus, receive a $200 statement credit when you spend $500 on purchases in your first 3 months of account opening
Annual Fee $0 Why we like it
/images/2025/01/23/discover_it_cash_back_card_art_gold.png)
/images/2025/02/04/person_using_card_in_atm.jpg)
/images/2020/06/29/pensive-woman-looking-at-laptop-screen.jpeg)
/images/2026/02/20/growing-wealth-pile-of-coins-growing-adding-money.jpg)
/images/2025/03/22/stressed_about_credit_card_debt.jpg)
/images/2026/08/17/woman-in-her-70s-looking-through-the-window.jpg)
/images/2023/09/21/senior-couple-spending-time-in-park.jpeg)
/images/2024/09/06/seniors-dining-at-restaurant.png)
/images/2026/07/01/23_mark-cuban-3.jpg)
/images/2025/09/06/senior-man-looking-worried-while-holding-credit-card.jpg)
/images/2025/08/21/rapid-income-growth-adobe.jpg)
/images/2025/04/02/person_using_credit_card_on_groceries.png)
